date/time interval
- March 1, 2021 - February 28, 2022
Improving transplant outcomes by quantifying and targeting measurable residual disease in Acute Myeloid Leukemia
Grant
- Overview
- Affiliation
- View All
Overview
awarded by
total award amount
- CAD 49905